BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu AM, Huang L, Liu W, Gao S, Han WX, Wei ZJ. Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials. PLoS One. 2014;9:e86941. [PMID: 24497999 DOI: 10.1371/journal.pone.0086941] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Huang L, Li TJ. Laparoscopic surgery for gastric cancer: where are we now and where are we going? Expert Rev Anticancer Ther 2018;18:1145-57. [PMID: 30187785 DOI: 10.1080/14737140.2018.1520098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ramachandra, Goel V, Raju K, Rao TS, Patnaik, Nusrath, Santa, Murthy S. Prospective Randomized Controlled Study Comparing Primary Surgery Versus Neoadjuvant Chemotherapy Followed by Surgery in Gastric Carcinoma. Indian J Surg Oncol 2019;10:245-50. [PMID: 31168243 DOI: 10.1007/s13193-019-00908-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Zhao JH, Gao P, Song YX, Sun JX, Chen XW, Ma B, Yang YC, Wang ZN. Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis. BMC Cancer 2016;16:631. [PMID: 27519527 DOI: 10.1186/s12885-016-2667-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
4 Long B, Yu ZY, Li Q, Du HR, Wang ZJ, Zhan H, Jiao ZY. A systematic review and network meta-analysis protocol of neoadjuvant treatments for patients with gastric cancer. Medicine (Baltimore) 2018;97:e0392. [PMID: 29642200 DOI: 10.1097/MD.0000000000010392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ramos MFKP, Pereira MA, Dias AR, Faraj SF, Zilberstein B, Cecconello I, de Mello ES, Ribeiro Junior U. Lymphoepithelioma-like gastric carcinoma: clinicopathological characteristics and infection status. J Surg Res 2017;210:159-68. [PMID: 28457323 DOI: 10.1016/j.jss.2016.11.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
6 Greenleaf EK, Hollenbeak CS, Wong J. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database. Surgery. 2016;159:1099-1112. [PMID: 26704785 DOI: 10.1016/j.surg.2015.11.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
7 Huang L, Xu AM. Adenocarcinoma of esophagogastric junction: controversial classification, surgical management, and clinicopathology. Chin J Cancer Res. 2014;26:226-230. [PMID: 25035645 DOI: 10.3978/j.issn.1000-9604.2014.06.14] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Kanda M, Kodera Y, Sakamoto J. Updated evidence on adjuvant treatments for gastric cancer. Expert Rev Gastroenterol Hepatol. 2015;9:1549-1560. [PMID: 26414453 DOI: 10.1586/17474124.2015.1094373] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
9 Zhang Y, Lin S, Chen Y, Yang F, Liu S. LDH-Apromotes epithelial-mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer. Onco Targets Ther 2018;11:2363-73. [PMID: 29740212 DOI: 10.2147/OTT.S163570] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Lordick F, Gockel I. Chances, risks and limitations of neoadjuvant therapy in surgical oncology. Innov Surg Sci 2016;1:3-11. [PMID: 31579713 DOI: 10.1515/iss-2016-0004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Xu W, Ma Q, Wang L, He C, Lu S, Ni Z, Hua Z, Zhu Z, Yang Z, Zheng Y, Feng R, Yan C, Li C, Yao X, Chen M, Liu W, Yan M, Zhu Z. Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy. Front Oncol 2021;11:607640. [PMID: 33937020 DOI: 10.3389/fonc.2021.607640] [Reference Citation Analysis]
12 Gabriel E, Attwood K, Narayanan S, Brady M, Nurkin S, Hochwald S, Kukar M. Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma? J Surg Oncol 2018;117:659-70. [DOI: 10.1002/jso.24894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang J, Sun Z, Yan S, Gao F. Effect of miR‑145 on gastric cancer cells. Mol Med Rep 2019;19:3403-10. [PMID: 30864704 DOI: 10.3892/mmr.2019.10015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Lowenfeld L, Datta J, Lewis RS, Mcmillan MT, Mamtani R, Damjanov N, Chandrasekhara V, Karakousis GC, Drebin JA, Fraker DL, Roses RE. Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival. Ann Surg Oncol 2015;22:863-72. [DOI: 10.1245/s10434-015-4677-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
15 Coccolini F, Nardi M, Montori G, Ceresoli M, Celotti A, Cascinu S, Fugazzola P, Tomasoni M, Glehen O, Catena F, Yonemura Y, Ansaloni L. Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials. Int J Surg. 2018;51:120-127. [PMID: 29413875 DOI: 10.1016/j.ijsu.2018.01.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
16 Hoeppner J. Chirurgische Strategie in der multimodalen Behandlung des Magen- und Ösophaguskarzinoms. Chirurg 2017;88:1005-9. [DOI: 10.1007/s00104-017-0545-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Kinoshita O, Ichikawa D, Ichijo Y, Komatsu S, Okamoto K, Kishimoto M, Yanagisawa A, Otsuji E. Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer. World J Gastroenterol 2015; 21(48): 13500-13506 [PMID: 26730161 DOI: 10.3748/wjg.v21.i48.13500] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
18 Yu JH, Wang ZZ, Fan YC, Liu MX, Xu K, Zhang N, Yao ZD, Yang H, Zhang CH, Xing JD, Cui M, Su XQ. Comparison of neoadjuvant chemotherapy followed by surgery vs. surgery alone for locally advanced gastric cancer: a meta-analysis. Chin Med J (Engl) 2021;134:1669-80. [PMID: 34397593 DOI: 10.1097/CM9.0000000000001603] [Reference Citation Analysis]
19 Chen ZM, Huang L, Li MM, Meng L, Ying SC, Xu AM. Inhibitory effects of isocryptotanshinone on gastric cancer. Sci Rep. 2018;8:9307. [PMID: 29915371 DOI: 10.1038/s41598-018-27638-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
20 Bracale U, Corcione F, Pignata G, Andreuccetti J, Dolce P, Boni L, Cassinotti E, Olmi S, Uccelli M, Gualtierotti M, Ferrari G, De Martini P, Bjelović M, Gunjić D, Cuccurullo D, Sciuto A, Pirozzi F, Peltrini R. Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score-matched study. J Surg Oncol 2021;124:1338-46. [PMID: 34432291 DOI: 10.1002/jso.26657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shen X, Hu K, Cheng G, Xu L, Chen Z, Du P, Zhuang Z. KDM5D inhibit epithelial‐mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male. J Cell Biochem 2019;120:12247-58. [DOI: 10.1002/jcb.27308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Huang L, Xu A. Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination. Front Med 2017;11:20-31. [PMID: 28213880 DOI: 10.1007/s11684-016-0493-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Russell MC. Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer. J Surg Oncol 2016;114:296-303. [PMID: 27511285 DOI: 10.1002/jso.24293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
24 Kim BJ, Chiang YJ, Das P, Minsky BD, Blum MA, Ajani JA, Estrella JS, Hofstetter WL, Tzeng CD, Badgwell BD, Mansfield PF, Ikoma N. Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States. J Clin Med 2020;9:E3495. [PMID: 33138060 DOI: 10.3390/jcm9113495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Seyfried F, von Rahden BH, Miras AD, Gasser M, Maeder U, Kunzmann V, Germer CT, Pelz J, Kerscher AG. Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer 2015;15:73. [PMID: 25879885 DOI: 10.1186/s12885-015-1081-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
26 Joo I, Kim SH, Ahn SJ, Lee ES, Shin CI, Lee HJ, Yang HK. Preoperative tumor restaging and resectability assessment of gastric cancers after chemotherapy: diagnostic accuracy of MDCT using new staging criteria. Abdom Radiol (NY) 2017;42:2807-15. [PMID: 28643135 DOI: 10.1007/s00261-017-1224-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Cai Z, Yin Y, Zhao Z, Xin C, Cai Z, Yin Y, Shen C, Yin X, Wang J, Chen Z, Zhou Y, Zhang B. Comparative effectiveness of neoadjuvant treatments for resectable gastroesophageal cancer: a network meta-analysis. Front Pharmacol. 2018;9:872. [PMID: 30127746 DOI: 10.3389/fphar.2018.00872] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
28 Ju T, Rivas L, Kurland K, Chen S, Sparks A, Lin PP, Vaziri K. National trends in total vs subtotal gastrectomy for middle and distal third gastric cancer. Am J Surg. 2020;219:691-695. [PMID: 31030990 DOI: 10.1016/j.amjsurg.2019.04.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Rong GX, Huang L, Gui BJ, Xu AM, Zhang JL, Wang SS. Female-specific vs conventional knee prostheses after total knee arthroplasty: A meta-analysis. World J Meta-Anal 2014; 2(4): 221-227 [DOI: 10.13105/wjma.v2.i4.221] [Reference Citation Analysis]
30 Yang B, Shi C, Lin X, Wang X, Chen Q. Retrospective study on efficacy of a paclitaxel combined with a leucovorin and fluorouracil regimen for advanced gastric cancer. Tumori Journal 2019;105:509-15. [DOI: 10.1177/0300891618792481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Miao ZF, Liu XY, Wang ZN, Zhao TT, Xu YY, Song YX, Huang JY, Xu H, Xu HM. Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis. BMC Cancer. 2018;18:118. [PMID: 29385994 DOI: 10.1186/s12885-018-4027-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
32 Cai Z, Yin Y, Shen C, Wang J, Yin X, Chen Z, Zhou Y, Zhang B. Comparative effectiveness of preoperative, postoperative and perioperative treatments for resectable gastric cancer: A network meta-analysis of the literature from the past 20 years. Surgical Oncology 2018;27:563-74. [DOI: 10.1016/j.suronc.2018.07.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
33 Chen D, You X, Pan Y, Liu Q, Cao G. TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial-mesenchymal transition in gastric cancer. Onco Targets Ther 2018;11:8803-13. [PMID: 30573971 DOI: 10.2147/OTT.S178446] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
34 Wang K, Ren Y, Ma Z, Li F, Cheng X, Xiao J, Zhang S, Yu Z, Yang H, Zhou H, Li Y, Liu H, Jiao ZY. Docetaxel, oxaliplatin, leucovorin, and 5-fluorouracil (FLOT) as preoperative and postoperative chemotherapy compared with surgery followed by chemotherapy for patients with locally advanced gastric cancer: a propensity score-based analysis. Cancer Manag Res 2019;11:3009-20. [PMID: 31114348 DOI: 10.2147/CMAR.S200883] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 de Mestier L, Lardière-Deguelte S, Volet J, Kianmanesh R, Bouché O. Recent insights in the therapeutic management of patients with gastric cancer. Dig Liver Dis. 2016;48:984-994. [PMID: 27156069 DOI: 10.1016/j.dld.2016.04.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
36 Krzysiek-Maczka G, Targosz A, Szczyrk U, Strzałka M, Sliwowski Z, Brzozowski T, Czyz J, Ptak-Belowska A. Role of Helicobacter pylori infection in cancer-associated fibroblast-induced epithelial-mesenchymal transition in vitro. Helicobacter 2018;23:e12538. [PMID: 30246423 DOI: 10.1111/hel.12538] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
37 Rinninella E, Strippoli A, Cintoni M, Raoul P, Vivolo R, Di Salvatore M, Genco E, Manfredi R, Bria E, Tortora G, Gasbarrini A, Pozzo C, Mele MC. Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study. Nutrients 2021;13:960. [PMID: 33809587 DOI: 10.3390/nu13030960] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Mazzei MA, Di Giacomo L, Bagnacci G, Nardone V, Gentili F, Lucii G, Tini P, Marrelli D, Morgagni P, Mura G, Baiocchi GL, Pittiani F, Volterrani L, Roviello F. Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer). Quant Imaging Med Surg 2021;11:2376-87. [PMID: 34079708 DOI: 10.21037/qims-20-683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Bringeland EA, Wasmuth HH, Grønbech JE. Perioperative chemotherapy for resectable gastric cancer – what is the evidence? Scandinavian Journal of Gastroenterology 2017;52:647-53. [DOI: 10.1080/00365521.2017.1293727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]